Marketing to the “Dead Internet”: Why Legacy AdTech Misses Real People
The “Dead Internet Theory” has gained quite a bit of traction since it was brought to light in 2021. According to The University of New South Wales the dead internet…
Using AI to Create Synergy Between HCP and DTC Marketing Strategies
Pharmaceutical marketing has long treated healthcare providers (HCPs) and patients as separate audiences. Distinct in their needs, their influence, and their channels of communication. But as the healthcare journey grows…
Privacy as an Innovation Driver: Removing the Reliance on Individual Health Data in Healthcare Marketing
As the regulatory landscape tightens around data privacy, many healthcare advertisers are forced to react, limiting functionality, scaling back targeting, or navigating consent challenges. BranchLab took a different path. From…
Why Banning Health Data Tracking Benefits Everyone, Even Advertisers
by Josh Walsh, Co-Founder & CEO, BranchLab A recent Harvard Law publication warns that Washington’s My Health My Data Act (WMHMD) could disrupt widely used advertising techniques. It’s right. And…
Protecting Patients and Performance
As regulations tighten, cleanroom technology offers a sustainable, compliant path forward for health advertising. The advertising technology ecosystem is at a crossroads. Eighty percent of consumers are concerned and confused…
How New York’s Recent Health Data Privacy Law Impacts Pharma Advertising
The advertising landscape is changing, especially for healthcare and pharmaceutical companies. This January, the New York Senate approved S929 – a groundbreaking data privacy law and significant step towards greater…
Could Washington State Transform Pharmaceutical Advertising Forever?
Unpacking the Pivotal Harvard Law Paper. Pharmaceutical advertising is undergoing a seismic shift, and Washington State is at the epicenter. A recent paper from Harvard Law has issued a transformative…
What could a new administration mean for healthcare advertising?
RFK Jr. has consistently advocated for a ban on pharmaceutical advertising, as evidenced by his discussions on prominent platforms like The Joe Rogan Experience and his social media posts, including…
Enhancing ROI with Privacy-Compliant Pharma Marketing: Insights from BranchLab
As the landscape of healthcare advertising evolves, how can brands effectively reach their audiences while ensuring data privacy? Fierce Pharma’s Michelle Benz sought to find the answer to this pressing…
MediaPost Webinar: Engaging HCP Audiences in the Era of Signal Loss
As a part of the MediaPost webinar series, we joined a session hosted by Causal IQ to discuss Healthcare Professionals (HCPs) and how to best reach & market to them…